European Society for Paediatric Endocrinology (ESPE 2024)
Presentation
European Society for Paediatric Endocrinology (ESPE 2024)
16-18 November 2024. Liverpool, UK.
Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies.
Gevers E, Bridges N, Yanovski J, et al.
Presentation
European Society for Paediatric Endocrinology (ESPE 2024)
16-18 November 2024. Liverpool, UK.
Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome.
Bridges N, Gevers E, Yanovski J, et al.
